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ABSTRACT: Myosteatosis is the pathologic accumulation of lipid that can occur in conjunction with atrophy and
fibrosis following skeletal muscle injury. Little is known about the mechanisms by which lipid accumulates in
myosteatosis, butmany clinical studies have demonstrated that the degree of lipid infiltration negatively correlates
with muscle function and regeneration. Our objective was to determine the pathologic changes that result in lipid
accumulation in injured muscle fibers. We used a rat model of rotator cuff injury in this study because the rotator
cuffmusclegroup isparticularlyprone to thedevelopmentofmyosteatosisafter injury.Muscleswere collected from
uninjured controls or 10, 30, or 60 d after injury and analyzed using a combination of muscle fiber contractility
assessments, RNA sequencing, and undirected metabolomics, lipidomics, and proteomics, along with bio-
informatics techniques to identify potential pathways and cellular processes that are dysregulated after rotator cuff
tear.Bioinformatics analyses indicated thatmitochondrial functionwas likelydisruptedafter injury.Basedon these
findings and given the role that mitochondria play in lipid metabolism, we then performed targeted biochemical
and imaging studies anddetermined thatmitochondrial dysfunctionand reduced fatty acid oxidation likely leads to
the accumulation of lipid in myosteatosis.—Gumucio, J. P., Qasawa, A. H., Ferrara, P. J., Malik, A. N., Funai, K.,
McDonagh, B., Mendias, C. L. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis.
FASEB J. 33, 7863–7881 (2019). www.fasebj.org
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Skeletal muscle often displays chronic degenerative
changes following injury, including atrophy and weak-
ness of muscle fibers and fibrotic changes to the extracel-
lular matrix (ECM) (1–4). Some muscles also display a
pathologic accumulation of lipid in response to chronic
injury or disease, which is referred to as myosteatosis or
fatty degeneration (5, 6). The rotator cuff muscle group,
which is composed of the supraspinatus (SSP), infra-
spinatus, teres minor, and subscapularis, moves and sta-
bilizes the shoulder joint and is particularly prone to
developingmyosteatosis after injury (7, 8).Chronic tearsof
the rotator cuff, which nearly always involve a tear to the
distal tendon of the SSP, infraspinatus, or subscapularis
and have similar clinical presentation and pathologic
changes, are among the most frequent upper-extremity
injuries in patients, with .250,000 surgical repairs per-
formed annually in the United States (7, 9). Patients with
these injuries have a 30% reduction in muscle fiber force
production and degenerative changes to the motor end-
plate consistent with partial denervation (1, 10). Lipid ac-
cumulation in injured rotator cuff muscles is correlated
with muscle weakness and poor patient outcomes fol-
lowing surgical repair (8, 11). Additionally, for most pa-
tients, the muscle does not regain strength and function
despite undergoing postoperative strengthening exercises
in rehabilitation, and nearly 40% of patients will actually
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continue to develop more atrophy and fat accumulation
after the repair (8).Asexcess lipidappears toplayanegative
role in muscle regeneration, developing therapeutic inter-
ventions to reducemyosteatosismay improveoutcomes for
patients with chronic muscle injuries and diseases. How-
ever, themechanisms that lead to the pathologic buildup of
lipid within muscle fibers are not well understood.
Our objective in the current study was to gain greater
insight into the biochemical pathways and cellular factors
that lead to myosteatosis after skeletal muscle injury. We
used a rat model of rotator cuff tears in which the SSP
musclewasdenervatedanddetached fromthehumerusby
removing the distal tendon. Muscles were then harvested
either 10, 30, or 60dafter the injuryandcomparedwithSSP
muscles of uninjured rats. We divided the study into 2
parts. First, we evaluated changes in muscle fiber force
production and performed a broad analysis of the changes
in the muscle lipidome, metabolome, transcriptome, and
proteome using mass spectrometry and RNA sequencing
(RNA-seq) techniques. Bioinformatics tools were used to
identify potential cellular processes and molecular targets
that were disrupted as a result of rotator cuff injury. This
analysis identified mitochondrial dysfunction as a strong
candidate in causing pathologic changes after muscle in-
jury. Based on these results, in the second half of the study,
we tested the hypothesis that pathologic lipid accumula-
tion occurs in torn rotator cuffs because of mitochondrial
dysfunction and reduced lipid oxidation.
MATERIALS AND METHODS
Animals
This study was approved by the University of Michigan In-
stitutional Animal Care and Use Committee. A total of 40 adult
male6-mo-old retired-breederSprague-Dawley ratswereused in
this study (n = 10 per group). The rat rotator cuff tenectomy and
denervationmodel was chosen because of anatomic similarity to
humans and because the model mimics many of the pathologic
changes observed in patients with chronic rotator cuff tears such
as fiber atrophy, lipid accumulation, and fibrosis (1, 3, 12–14).
Additionally, the degree of retraction of both chronic human and
rat SSP tears is;20% (15–17), suggesting similarities in changes
to the muscle architecture between the rat model and patients
with SSP tears. Bilateral SSP tears were administered as pre-
viously described in refs. 12, 14, and 15. Animals were deeply
anesthetized with 2% isoflurane, and the surgical area was
shaved and scrubbed with chlorhexidine. A deltoid-splitting
transacromial approach was used to expose the SSP tendon. A
tenectomy was performed to remove the tendon because the
tendons of rats can spontaneously reattach to the humerus or
surrounding fascia (18). The tenectomy was performed by
attachingasurgical clamp to thedistal endof the tendonand then
finely detaching the tendon from its footprint on the humeral
head. Using the clamp to maintain tension, the tendon was then
finely transected just distal to the myotendinous junction,
allowing for removal of the tendon without directly causing
damage to the muscle during the procedure. Following ten-
ectomy, the suprascapular nerve was located, and a ;3–4-mm
segment was removed to denervate the muscle. An overview of
the tenectomy anddenervation procedure is provided in Fig. 1A.
The deltoid muscle and skin were then closed, and the animals
were allowed to recover in their cages. Rats were treated with
buprenorphine twice postoperatively (0.05 mg/kg; Reckitt
Benckiser, Slough, United Kingdom) and a single dose of
carprofen (5 mg/kg; Zoetis, Parsippany-Troy Hills, NJ, USA).
Animals were closely monitored thereafter for signs of pain or
distress. After a period of either 10, 30, or 60 d, animals were
anesthetized with sodium pentobarbital (40 mg/kg; Vortech
Pharmaceuticals, Dearborn, MI, USA), and SSP muscles were
harvested and weighed and portions were prepared for either
histology or single-fiber contractility. The remaining tissue was
finely minced and snap frozen in 25–50-mg aliquots for bio-
chemical and molecular biology measures. Animals were then
euthanized by overdose of sodium pentobarbital followed by
induction of a bilateral pneumothorax.
Histology
Histology was performed as described by Gumucio et al. (12).
Distal portions of the SSPwereplaced in tragacanthgumand snap
frozen in isopentane cooled with liquid nitrogen. The 10-mm sec-
tions were fixed with 4% paraformaldehyde, incubated in 0.2%
TritonX-100, and thenstainedwithwheatgermagglutinin (WGA)
conjugated toAlexa Fluor 555 (ThermoFisher Scientific,Waltham,
MA, USA) to label the ECM, DAPI (MilliporeSigma, Burlington,
MA, USA) to identify nuclei, and boron-dipyrromethene
(BODIPY) 493/503 (Thermo Fisher Scientific) to label neutral lip-
ids. To calculate fiber cross-sectional areas (CSAs), images of
WGA- and DAPI-stained sections were taken on an Evos FL mi-
croscope (Thermo Fisher Scientific), and CSAs were calculated
using ImageJ (National Institutes of Health, Bethesda,MD,USA).
Images stainedwithWGA,DAPI, and BODIPYwere taken using
the AxioPhot system (Carl Zeiss, Oberkochen, Germany).
Muscle fiber contractility
The contractility of chemically permeabilized muscle fibers was
performed as previously described (1, 12). Briefly, fiber bundles
were dissected from the proximal region of SSP muscles, placed
in skinning solution for 30 min, and then placed in storage so-
lution for 16h at 4°C followedby storage at280°C.On the day of
contractility testing, samples were thawed slowly on ice, and
individual fibers were pulled from bundles using fine mirror-
finished forceps. Fiberswere thenplaced in a chamber containing
relaxing solution and secured at 1 end to a servomotor (Aurora
Scientific, Aurora, ON, Canada) and the other end to a force
transducer (Aurora Scientific) with 2 ties of 10-0 monofilament
nylon suture.Usinga laserdiffractionmeasurement system, fiber
length was adjusted to obtain a sarcomere length of 2.5 mm. The
mean fiber CSA was calculated assuming an elliptical cross sec-
tion, with diameters obtained at 5 positions along the length of
the fiber from high-magnification images taken of top and side
views. Because the permeabilization process causes swelling of
fibers, the CSAs measured with this technique will be greater
than those measured using histology (19). Maximum isometric
force (Fo) was elicited by immersing the fiber in a high calcium
activation solution. Specific maximum isometric force (sFo) was
calculated by dividing Fo by fiber CSA. An overview of the ex-
perimental setup and formulas is shown in Fig. 1B–D. Fibers
were categorized as fast or slow by examining their force re-
sponse to rapid, constant-velocity shorteningmaneuver inwhich
slow fibers are unable to maintain force production while
shortening, whereas fast fibers contract rapidly enough to
maintain force as they shorten (20). A total of 10–20 fast fibers
were tested from each SSP muscle.
Western blots
Western blots were performed as described by Sugg et al. (21).
Protein was isolated from snap-frozen 25-mg aliquots of muscle
tissue and placed in 500 ml of a solution containing Total Protein
Extraction Reagent (Thermo Fisher Scientific) with 1% Nonidet
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P-40 and 1% protease-phosphatase inhibitor (Thermo Fisher
Scientific). Samples were homogenized, vortexed at 4°C for
30 min, and then centrifuged at 12,000 g for 15 min at 4°C. The
supernatant was collected and saved at 280°C until use. The
pellets of insoluble proteins were saved for hydroxyproline as-
says as described below. Protein concentration was determined
withabicinchoninic acidassay (ThermoFisherScientific). Protein
(20–100 mg) was loaded into 6–12% polyacrylamide gels and
subjected to electrophoretic separation.Proteinswere transferred
onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA)
and blocked for 1 h in 3–5% skimmilk. Membranes were rinsed
and incubatedovernight inprimaryantibodies at a concentration
of 1:1000 against either glutathione (101A; ViroGen,Watertown,
MA, USA), succinate dehydrogenase-A (SDHA, 11998; Cell
Signaling Technology, Danvers, MA, USA), cytochrome c oxi-
dase subunit 4 (COX4, 4850; Cell Signaling Technology), phos-
phorylated (p)–IGF1R Y1135 (3918; Cell Signaling Technology),
IGF1R (9750; Cell Signaling Technology), p-ERK1/2 T202/Y204
(4370; Cell Signaling Technology), ERK1/2 (4695; Cell Signaling
Technology), p–protein kinase B (Akt) S473 (4060; Cell Signaling
Technology), Akt (4691; Cell Signaling Technology), p–p70S6
kinase (p70S6K) T389 (9234; Cell Signaling Technology), p-
p70S6K T421/S424 (9204; Cell Signaling Technology), p70S6K
(2708; Cell Signaling Technology), p–ribosomal protein S6 (rpS6)
S235/S236 (4858; Cell Signaling Technology), rpS6 (2217; Cell Sig-
naling Technology), p62 (129012; Abcam, Cambridge, United
Kingdom),ULK1(128859;Abcam),PINK1(23707;Abcam),Parkin
(15954;Abcam), peroxiredoxin (Prdx) 3 (128953;Abcam), or Prdx6
(133348; Abcam). After primary antibody incubation, membranes
were rinsed and incubated in goat anti-rabbit or goat anti-mouse
horseradish peroxidase–conjugated secondary antibodies (from
either Abcam or Cell Signaling Technology). Proteins were de-
tected using Clarity Western ECL Substrate (Bio-Rad) or Super
Signal West Dura (Thermo Fisher Scientific) and imaged and
quantified using a ChemiDoc chemiluminescent detection system
(Bio-Rad). Phosphoprotein quantification between blots was nor-
malized to pooled standards run in each gel to allow us to assess
themagnitude of signal transduction across tissues. Coomassie or
Ponceau S staining of membranes was performed to verify equal
protein loading.
Hydroxyproline content
Hydroxyproline was measured from the insoluble fraction
remaining from the isolation of soluble proteins for Western
blots. Pellets were dried at 100°C overnight, weighed immedi-
ately, and then hydrolyzed in 12 M hydrochloric acid. Samples
were then evaporated in a SpeedVac (Thermo Fisher Scientific),
and hydroxyproline was determined using a colorimetric assay
as previously described by Mendias et al. (22).
Electron microscopy
Portions of distal SSP muscles were fixed in 1% tannic acid and
1%glutaraldehyde in Sorenson’s buffer followed by postfixation
in 2%osmium tetroxide (ElectronMicroscopy Sciences,Hatfield,
PA,USA). Sampleswere thendehydratedusingagradedethanol
series and embedded in Embed 812 (Electron Microscopy Sci-
ences) using a graded resin and propylene oxide series. The 1-m
Figure 1. Experimental overview. A) Overview of the surgical model, demonstrating a tenectomy and denervation of the SSP
muscle by removal of a segment of the branch of the suprascapular nerve that innervates the SSP muscle. The infraspinatus and
the branch of the suprascapular nerve that innervates the infraspinatus, which passes deep to the SSP and through the
spinoglenoid notch, was left intact and innervated. The 2 other rotator cuff muscles, the teres minor and subscapularis, were also
left intact and innervated but are not illustrated. The spine of the scapula and acromion are also not shown for clarity of
illustration. B, C) Overview of experimental setup demonstrating the position of the fiber in the testing apparatus (B) and the
procedure to measure CSA obtained from 5 equally spaced regions along the length of the fiber (C). D) An illustrative force trace
demonstrating an isometric contraction in response to calcium stimulation and equations to determine sFo from Fo and CSA.
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transverse sections were cut with a diamond knife ultramicro-
tome and imaged using a Jeol 1400-plus transmission electron
microscope (Jeol, Tokyo, Japan) with a high-resolution digital
camera (AMT, Woburn, MA, USA).
Lipidomics and metabolomics
TheUniversity ofMichiganMetabolomics Core performedmass
spectrometry–based shotgun lipidomics and metabolomics
measurements from snap-frozen, homogenized muscle samples
as previously described in refs. 23 and 24. For lipidomics, lipids
were extracted fromsampleswith a solventmixture consisting of
2:2:2 (v/v/v) methanol:dichloromethane:water at room tem-
peratureafter adding internal standardmixture.Afterdrying, the
sampleswere resuspended inasolutioncontaining1:5:85 (v/v/v)
acetonitrile:water:isopropanol and 10mM ammonium acetate.
Samples were then subjected to liquid chromatrography–mass
spectrometry (MS), and MS peaks were matched in silico with
LipidBlast (25). Quantification was performed by Multiquant
software (Danaher,Washington, DC,USA). Formetabolomics,
metabolites were extracted from frozen muscle in a solvent
mixture containing 8:1:1 methanol:chloroform:water (v/v/v).
Reverse phase liquid chromatography–quadrupole tandemMS
(MS/MS) was used to measure acylcarnitines (26). Other me-
tabolites were derivatized and analyzed with GC-MS. Quanti-
fication of metabolites was performed using Masshunter
Quantitative Analysis software (Agilent Technologies, Santa
Clara, CA,USA). Normalized abundance data for allmeasured
metabolites is provided in Supplemental Material S1.
RNA-seq and gene expression
Snap-frozen aliquots of muscle tissue were homogenized in
Qiazol (Qiagen, Hilden, Germany) and isolated using an miR-
Neasy kit (Qiagen). RNA concentration was determined using
a NanoDrop 2000 (Thermo Fisher Scientific). For each sample,
250 ng total RNA was delivered to the University of Michigan
Sequencing Core for RNA-seq analysis. Sample concentrations
were normalized, and cDNApoolswere created for each sample
and then subsequently tagged with a barcoded oligo adapter to
allow for sample-specific resolution. Sequencing was carried out
using an Illumina HiSeq 2500 platform (Illumina, San Diego, CA,
USA)with 50-bp single-end reads. RawRNA-seq datawas quality
checked using FastQC v0.10.0 (Barbraham Bioinformatics, Cam-
bridge, United Kingdom). Alignment to the reference genome
(rn5, University of California–Santa Cruz, CA, USA), differential
expression based on counts per million mapped reads, and post-
analysis diagnostics were carried out using the Tuxedo Suite soft-
ware package (27). RNA-seq data has been deposited to the
National InstitutesofHealth (Bethesda,MD,USA)GeneExpression
Omnibus (GEO) (accession GSE103266; https://www.ncbi.nlm.nih.
gov/geo/), and normalized counts per million mapped reads values
for all measured genes are provided in Supplemental Material S1.
To validate fold-change RNA-seq data, we performed quan-
titative PCR (qPCR) on a select set of genes. RNA was reverse
transcribed into cDNA with iScript Reverse Transcription
Supermix (Bio-Rad). Amplification of cDNAwas performed in a
CFX96 real-time thermal cycler (Bio-Rad) using iTaq Universal
SYBR Green Supermix (Bio-Rad). Target gene expression was
normalized to the stable housekeeping gene eukaryotic trans-
lation initiation factor 2B subunit b, and further normalized to
0 d samples using the 22DDCt method. Primer sequences are
provided in Supplemental Material S2.
Proteomics
Label-free proteomic analysis was performed as described by
McDonagh et al. (28). Aliquots were homogenized in 50 mM
ammoniumbicarbonate containing25mMN-ethyl-d0-malemide
(d (0) NEM), pH 8. Protein lysates were prepared by centrifu-
gation at 15,000 g for 10 min at 4°C, and protein concentrations
were calculated using a Bradford assay (Bio-Rad) with bovine
serum albumin as a standard. Excess d (0) NEM was removed
using Zeba desalting columns (Thermo Fisher Scientific), and
protein concentrationswere determinedagain byBradford assay
as before.A total of 100mgofprotein extractwasdiluted to 160ml
with 25mM ammonium bicarbonate, denatured by the addition
of 10 ml of 1% RapiGest (Waters, Milford, MA, USA) in 25 mM
ammonium bicarbonate, and incubated at 80°C for 10 min with
shaking.Then, 10ml of a 100-mMsolutionofTris(2-carboxyethyl)
phosphine hydrochloride was added to reduce reversibly oxi-
dized cysteine (Cys) residues, followed by incubation at 60°C for
10 min. Newly reduced Cys was then alkylated by addition of
N-ethyl-d5-malemide and incubated at room temperature for
30 min. An aliquot of the samples was used at this point to check
theprocedurebySDS-PAGE.Proteolyticdigestionwasperformed
by addition of trypsin followed by overnight incubation at 37°C.
Digestion was terminated, and RapiGest was removed by acid-
ification (3 ml TFA incubated at 37°C for 45 min) and centrifu-
gation (15,000 g for 15 min).
Samples were analyzed using an Ultimate 3000 RSLC Nano
system (Thermo Fisher Scientific) coupled to a QExactive mass
spectrometer (Thermo Fisher Scientific). A total of 2ml of sample
corresponding to 1mg of proteinwas diluted in 18ml buffer (97%
H2O, 3% acetonitrile, and 0.1% formic acid v/v), and 5ml (250 ng
of protein) was loaded onto the trapping column (PepMap 100,
C18, 75mm3 20mm;ThermoFisher Scientific) usingpartial loop
injection for7min at a flowrate of 4ml/minwith 0.1% (v/v)TFA.
Sampleswere resolvedon theanalytical column (Easy-SprayC18
75mm3 400mm, 2-mmcolumn; Thermo Fisher Scientific) using
gradient of 97%A(0.1% formic acid) and3%B (99.9%acetonitrile
and 0.1% formic acid) to 60%Aand40%B over 120min at a flow
rate of 300 nl/min. Data-dependent acquisition consisted of a
70,000-resolution full-scan MS scan (automatic gain control set
to 106 ions with a maximum fill time of 250 ms), and the 10
most abundant peaks were selected for MS/MS using a 17,000-
resolution scan (automatic gain control set to 53 104 ions with a
maximum fill time of 250 ms) with an ion selection window of
3m/z andnormalized collision energyof30.Repeated selectionof
peptides forMS/MSwas avoidedwith a 30-s dynamic exclusion
window.
Label-free relative quantification was performed using
PEAKS7 software (Bioinformatics Solutions, Waterloo, ON,
Canada). The acquired Thermo RAW data files were searched
against the Universal Protein (UniProt) rat database (2015-29-07,
32,991 sequences; https://www.uniprot.org/) and analyzed using
the following parameters: peptide mass tolerance 10 ppm; frag-
ment mass tolerance 0.01 Da, 1+, 2+, 3 = ions; missed cleavages.
Variable modifications included in search were d (0) NEM, d (5)
NEM, mon-, di-, and trioxidation of Cys residues, and oxidation
ofmethioninewith a false discovery rate (FDR) of,1% searched
against the UniProt rat database. Normalization was carried out
using the total ion current. PEAKS7 software includes a post-
translational modification (PTM) algorithm applying the de novo
sequencing module to search for a limited number of PTMs. All
identified PTMs using this method adhere to the above search
criteria and FDR validation. All proteomics data has been de-
posited to the ProteomeXchange Consortium (accession
PXD009034; http://www.proteomexchange.org/), and normalized
abundance data for all measured proteins is provided in Sup-
plemental Material S1.
Bioinformatics
Expression data from RNA-seq measurements was imported
into Ingenuity Pathway Analysis (IPA) software (Qiagen) to as-
sist in predicting cellular andmolecular pathways and processes
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involved in myosteatosis. For metabolomics, lipidomics, and
proteomics measures, MS peak data was imported into
MetaboAnalyst 4.0 software (29) for data visualization, prin-
cipal component (PC) analysis, and statistical analyses.
Mitochondrial DNA measurements
Mitochondrial genome copy number quantification was per-
formed with modifications from a previous study (30). Total
DNA was isolated from aliquots of muscle tissue using the
DNeasy Blood and Tissue Kit (Qiagen). DNA was amplified via
qPCRas described abovewith customprimers formitochondrial
DNA (mtDNA) and b-2-microglobulin genomic DNA (gDNA)
(SupplementalMaterial S2).Usingknown standards of ratDNA,
standard curveswere generated for each primer set to determine
number of copies of either mtDNA or gDNA. The ratio of
mtDNA:gDNA was calculated per sample, and the mean was
calculated across groups.
Mitochondrial enzymatic assays
Freshly minced SSP tissue (50 mg) was isolated and placed in
500ml ice-cold PBS containing protease inhibitor (Thermo Fisher
Scientific). Samples were homogenized, and then 100 ml of 10%
laurelmaltoside and 400ml cold PBSwith protease inhibitor was
added. Samples were incubated on ice for 30 min and then
centrifuged at 12,000 g for 20 min at 4°C. Samples were stored at
280°C until use. On the day of measurement, samples were
thawedon ice, andprotein concentrationwasdeterminedusinga
bicinchoninic acid assay (Thermo Fisher Scientific). Colorimetric
enzymatic assays for mitochondrial complex I, II, and IV were
performed as per the manufacturer’s protocol (Abcam). Sample
concentrationwas optimized per assay in pilot experiments, and
equal protein was loaded per well. Samples were measured in
duplicate in a BioTek Epoch2 microplate spectrophotometer
(BioTek Instruments, Winooski, VT, USA). Optical density of
enzymatic activity per minute was calculated per the manufac-
turer’s protocol.
Pyruvate and palmitate oxidation measurements
Samples were placed into ice-cold medium containing 250 mM
sucrose, 1mMEDTA, 10mMTris-HCl, and 2mMATP (pH 7.4).
To isolate intact mitochondria, muscles were finely minced in
20 ml of medium per milligram of muscle and homogenized in a
glass homogenization tube with a motor-driven Teflon pestle
(31). Pyruvate andpalmitate oxidation assayswere performedas
previouslydescribed (withminormodification) byKim et al. (32).
Briefly, 80 ml tissue homogenate was added to incubation wells
on a sealed, modified, 48-well plate with a channel cut between
the adjacent trap wells. The trap wells contained 200 ml of 1 M
sodiumhydroxide for the collection of liberated 14CO2. A total of
2 volumes of incubation buffer (100 mM sucrose, 10 mM Tris-
HCl, 5 mM potassium phosphate, 80 mM potassium chloride,
1 mM magnesium chloride, 0.1 mM malate, 2 mM ATP, 1 mM
DTT, 0.2 mM EDTA, 1 mM L-carnitine, 0.05 mM coenzyme A
(CoA), and 0.5% fatty acid–free bovine serum albumin, pH 7.4)
was added to the wells to initiate the reaction with 1 mM pyru-
vate ([2-14C]pyruvate at 0.5 mCi/ml) or 0.2 mM palmitate
([1-14C]palmitate at 0.5mCi/ml). Following 60min of incubation
at 37°C, 100ml of 70%perchloric acidwas added to terminate the
reaction.The trapwellswere sampled for label incorporation into
14CO2, which was determined by scintillation counting using
4 ml of Uniscint BD (National Diagnostics, Atlanta, GA, USA).
Statistics
Differences between groups were measured using 1-way
ANOVA (a = 0.05) followed by Fisher’s least significant differ-
ence post hoc sorting (a = 0.05), or Kruskal-Wallis tests (a = 0.05)
followed by Dunn’s post hoc sorting (a = 0.05). An FDRmultiple-
observation adjustment (q , 0.05) was applied to metabolomic,
lipidomic, proteomic, and RNA-seq data. Statistical analyses
were performed using Prism 6.0 (GraphPad Software, La Jolla,
CA, USA), Tuxedo, or MetaboAnalyst 4.0 (29).
RESULTS
Following muscle injury, the mass of muscles and size of
muscle fibers decreased over time (Fig. 2A, B). Collagen
content also accumulated after muscle injury, with a near
4-fold increase at 30 and 60d comparedwith controls (Fig.
2C). An accumulation of lipids within muscle fibers was
noted after muscle injury in both high-magnification his-
tology and electron microscopy, as well as disrupted
Figure 2. Changes in muscle mass, fiber size,
collagen content, and lipid accumulation after
rotator cuff tear. A–C) Mass (A), muscle fiber
histology CSA values (B), and hydroxyproline
content of muscles following rotator cuff tear
(C). D) Representative histology of areas of
muscle demonstrating lipid accumulation, with
neutral lipids in green, ECM in red, and nuclei
in blue. Scale bar for each panel is 20 mm.
Arrowheads indicate centrally located nuclei at
10 d. Data are presented as means 6 SD, n $ 6
muscles per group. Post hoc sorting (P , 0.05):
a, different from 0 d; b, different from 10 d; c,
different from 30 d.
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myofibril architecture (Fig. 2D, 3A). Centrally located nu-
clei were also noted 10 d after injury (Fig. 2D). In addition
to a reduction in size,muscle fiberswere alsoweaker, both
in terms of absolutemaximum isometric force and specific
force (Fig. 3B–D).
Given the reduction in muscle fiber size, we then mea-
suredactivationof the IGF1andERKpathways because of
their importance in maintaining muscle mass (Fig. 4). Re-
duced proximal IGF1 and ERK signaling was observed
after muscle injury, with corresponding reductions in Akt
S473 and p70S6K T421 and S424, although rpS6 S235 and S236
phosphorylation was increased 10 and 30 d after muscle
injury (Fig. 4).
To further quantify and explore the grossly apparent
lipid that accumulated after rotator cuff tear, we per-
formed shotgun lipidomics and detected 457 lipid species,
with summary data presented in Fig. 5. In general, PC
analysis demonstrated that the 10-d injurygroupdiverged
somewhat from uninjured muscles, whereas the 30- and
60-d injury groups were fairly distinct from uninjured
muscles but had some overlap with the 10-d group (Fig.
5A). For free fatty acids (FFAs), there was an increase in
oleate, palmitate, and stearate 30 and60d after rotator cuff
tear (Fig. 5B). Triglycerides (TGs) were the major class of
lipid species measured in muscle tissues and increased by
over 3-fold at the 60-d time point (Fig. 5C). Ceramide
phosphates, sphingomyelins, phosphatidylglycerols, phos-
phatidylinositols, and phosphatidylserines (Fig. 5G, H, J–L)
displayed similar patterns of change as TGs, whereas diglyc-
erides (DGs), monoglycerides, cholesterol esters, phospha-
tidicacids,phosphatidylcholines,phosphatidylethanolamines,
lysophosphatidylcholines, lysophosphatidylethanolamines,
and plasmenyl-phosphatidylcholines (Fig. 5D–F, I, M–Q)
displayedbiphasic responses.Nodifferences inplasmenyl-
phosphatidylethanolamines (Fig. 5R) were observed.
Next, we analyzed the levels of 68 small molecule me-
tabolites important formuscle function. Selectmetabolites
are presented in Fig. 6, with additional species listed in
Supplemental Material S1. There was a general similarity
of metabolites at the 0- and 10-d time points and at the 30-
and 60-d time points (Fig. 6A). Several nucleoside and
nucleotide metabolites, such as ADP, cytidine mono-
phosphate, guanosinemonophosphate,NAD,anduridine
monophosphate decreased after rotator cuff tear (Fig.
6B). An increase in metabolites involved in glycolysis
and pentose phosphate metabolism, such as fructose-
bisphosphate, hexoses, hexose-phosphate, and phospho-
enolpyruvate, increased at 30 and 60 d after muscle injury
(Fig. 6D). There were changes in only a few free amino
acids suchasalanine, aspartate, threonine, andtryptophan
(Fig. 6E), and no changes were observed in the creatine
phosphate shuttle, Krebs cycle metabolites, or free gluta-
thione after injury (Fig. 6C, F, H).
We thenperformedRNA-seq to analyzeglobal changes
in the transcriptome of injured muscles. The PC analyses
demonstrated divergence across the different time points,
with the 10- and 30-d time points demonstrating the most
difference fromcontrols (Fig. 7A). IPAwasused to identify
potential biologic pathways and functions that were af-
fected by rotator cuff tear, and we observed several
processes related to lipid metabolism and mitochondrial
function, reactive oxygen species (ROS) production, gly-
colysis, muscle contraction, ECM production, and in-
flammation that were predicted to be differentially
regulated in myosteatosis (Table 1). We then selected
numerous genes related to these processes from RNA-
seq to further explore and report in Fig. 7. We also
performed qPCR to validate selected genes from the
different categories, and generally observed similar
trends in differential regulation between RNA-seq and
qPCR data (Table 2).
At 10 d after rotator cuff tear, there was a general trend
for a down-regulation in genes involved in muscle con-
traction, such as the myosin heavy chain (MYH) genes
(Myh1, Myh2, Myh4, and Myh7) and other sarcomeric
genes such as myosin binding protein c 1 and 2, myosin
light chain 1, myopalladin, and troponin I2, as well as
an increase in the membrane repair gene dysferlin (Dysf;
Figure 3. Changes in myofibrillar architecture
and muscle fiber contractility after rotator cuff
tear. A) Representative electron micrographs
taken in the middle of the fiber demonstrating
disrupted sarcomere ultrastructure in SSP
muscles following injury. Scale bar for each
panel is 2 mm. Arrowheads indicate lipid-laden
mitochondria. B–D) CSA (B), Fo (C), and sFo
(D) of permeabilized muscle fibers from
control and injured muscles. n = 10 muscles
per group. Post hoc sorting (P , 0.05): a,
different from 0 d; b, different from 10 d; c,
different from 30 d.
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Fig. 7B and Table 2). Many of these genes returned to base-
line by 60 d, although, of note, embryonic Myh3 remained
elevated throughout the study (Fig. 7B and Table 2).
Numerous autophagy and proteosome genes such
as beclin-1, m-calpain, and MUSA-1 were induced
10 d after injury (Fig. 7C), as were several genes
Figure 4. Changes in IGF1 signaling after rotator cuff tear. A–F) Quantification of band densitometry of p-IGF1R Y1135 (A),
p-ERK1/2 T202/Y204 (B), p-Akt S473 (C), p-p70S6K T389 (D), p-p70S6K T421/S424 (E), and p-rpS6 S235/S236 (F) following rotator
cuff tear normalized first to total protein and then to pooled standards across membranes. G) Representative phospho and total-
protein Western blots with a Coomassie-stained membrane as a loading control. Data are presented as means 6 SD, n = 6 per
group. Post hoc sorting (P , 0.05): a, different from 0 d; b, different from 10 d; c, different from 30 d.
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Figure 5. Changes in lipid species after rotator cuff tear. A) Principal component (PC) analysis of groups C-R. B–R) Levels of
FFAs (B), TGs (C), DGs (D), monoglycerides (MGs) (E), cholesterol ester (CE) (F), ceramide phosphates (CerPs) (G),
sphingomyelins (SMs) (H), phosphatidic acids (PAs) (I), phosphatidylglycerols (PGs) (J ), phosphatidylinositols (PIs) (K),
phosphatidylserines (PSs) (L), phosphatidylcholines (PCs) (M), phosphatidylethanolamines (PEs) (N), lysophosphatidylcho-
lines (LysoPCs) (O), lysophosphatidylethanolamines (LysoPEs) (P), plasmenyl-phosphatidylcholines (Plasmenyl PCs) (Q), and
plasmenyl-phosphatidylethanolamines (Plasmenyl PEs) (R) as measured by mass spectrometry and presented as relative peak
intensity (RPI). Data are presented as means 6 SD, n = 10 muscles per group (A, C–R); n = 5 muscles per group (B). Post hoc
sorting (P , 0.05): a, different from 0 d; b, different from 10 d; c, different from 30 d.
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involved with inflammation, atrophy, and fibrosis, like
GDF-11, IL-1b, and TGF-b (Fig. 7C, D). However, no
difference in the atrophy-inducing signaling molecules
activin A or B and a down-regulation in myostatin was
observed. IGF1 and bone morphogenetic protein 7,
which can activate pathways that promote muscle hy-
pertrophy, were up-regulated after rotator cuff tear
(Fig. 7D).
Figure 6. Changes in metabolites after rotator cuff tear. A) Principal component (PC) analysis of groups. B–G) Baseline
normalized heatmaps demonstrating levels of selected nucleotide and nucleoside metabolites (B), creatine and phosphocreatine
(C), glycolysis and pentose phosphate metabolites (D), free amino acids (E), Krebs cycle metabolites (F), and oxidized and
reduced glutathione (G) as measured by mass spectrometry. n = 5 muscles per group. Post hoc sorting (P, 0.05): a, different from
0 d; b, different from 10 d; c, different from 30 d. 2PG+3PG, 2-phosphoglycerate and 3-phosphoglycerate; CIT+ICIT, citrate and
isocitrate; CMP, cytidine monophosphate; F6P+G6P, fructose-6-phosphate and glucose-6-phosphate; FAD, flavin adenine
dinucleotide; GDP, guanosine diphosphate; GMP, guanosine monophosphate; NAD, nicotinamide adenine dinucleotide; NADP,
nicotinamide adenine dinucleotide phosphate; R5P+X5P, ribulose 5-phosphate and xylulose 5-phosphate; UDP, uridine
diphosphate; UMP, uridine monophosphate; UTP, uridine triphosphate.
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Figure 7. Changes in the transcriptome after rotator cuff tear. A) Principal component (PC) analysis of overall changes across the
transcriptome. B–I) Levels of selected contractile and structural genes (B), autophagy and atrophy genes (C), growth factors and
cytokines (D), ECM genes (E), glycolysis genes (F), lipid storage and mobilization genes (G), mitochondrial and oxidative
metabolism genes (H), and ROS and peroxisomal oxidation genes (I) as measured by RNA-seq. n = 4 muscles per group. Post hoc
sorting (P , 0.05): a, different from 0 d; b, different from 10 d; c, different from 30 d. Acadl, Acyl-Coa Dehydrogenase, Long
Chain; Acadm, Acyl-Coa Dehydrogenase, C-4 To C-12 Straight Chain; Acads, Acyl-Coa Dehydrogenase, C-2 To C-3 Short Chain;
Aco2, Aconitase 2; Acox1, Acyl-Coa Oxidase 1; Acsl1, Acyl-Coa Synthetase Long-Chain Family Member 1; Acsl6, Acyl-Coa
Synthetase Long-Chain Family Member 6; Acsm5, Acyl-Coa Synthetase Medium-Chain Family Member 5; Acss1, Acyl-Coa
Synthetase Short-Chain Family Member 1; Agpat1, 1-Acylglycerol-3-Phosphate O-Acyltransferase 1; Agpat3, 1-Acylglycerol-3-
Phosphate O-Acyltransferase 3; Agpat6, 1-Acylglycerol-3-Phosphate O-Acyltransferase 6; Agpat9, 1-Acylglycerol-3-Phosphate O-
Acyltransferase 9; Aldoa, Aldolase, Fructose-Bisphosphate A; Apoe, Apolipoprotein E; Atp5g1, Atp Synthase, H+ Transporting,
Mitochondrial Fo Complex Subunit C1 ; Becn1, Beclin 1; Bmp7, Bone Morphogenetic Protein 7; Capn2, Calpain 2/m-calpain;
Cat, Catalase; Cd36, Cd36 Molecule/fatty acid transporter; Col1a1, Collagen Type I Alpha 1 Chain; Col3a1, Collagen Type Iii
Alpha 1 Chain; Col4a1, Collagen Type Iv Alpha 1 Chain; Col6a2, Collagen Type Vi Alpha 2 Chain; Col14a1, Collagen Type Xiv
Alpha 1 Chain; Cox4i1, Cytochrome C Oxidase Subunit Iv Isoform 1; Cpt1b, Carnitine Palmitoyltransferase 1B; Cpt2, Carnitine
Palmitoyltransferase 2; Cs, Citrate Synthase; Cyc1, Cytochrome C-1; Cyp4b1, Cytochrome P450, Family 4, Subfamily B,
Polypeptide 1; Des, Desmin; Dgat1, Diacylglycerol O-Acyltransferase 1; Dgat2, Diacylglycerol O-Acyltransferase 2; Dysf, Dysferlin;
Eln, Elastin; Eno3, Enolase 3; Fabp4, Fatty Acid Binding Protein 4; Fasn, Fatty Acid Synthase; Fbp2, Fructose-Bisphosphatase 2;
Fbxo30, F-Box Protein 30/muscle ubiquitin ligase of SCF complex in atrophy-1 (MUSA-1); Fbxo32, F-Box Protein 32/atrogin-1/
MAFbx; Fh, Fumarate Hydratase; Gapdh, Glyceraldehyde-3-Phosphate Dehydrogenase; Gdf11, Growth Differentiation Factor 11;
Gpam, Glycerol-3-Phosphate Acyltransferase, Mitochondrial; Gpi, Glucose-6-Phosphate Isomerase; Gpx1, Glutathione Peroxidase 1;
Gpx3, Glutathione Peroxidase 3; Hk2, Hexokinase 2; Idh2, Isocitrate Dehydrogenase) 2, Mitochondrial; Igf1, Insulin Like
Growth Factor 1; Il1b, Interleukin 1 Beta; Il23a, Interleukin 23 Subunit Alpha; Il6, Interleukin 6; Inhba, Inhibin Beta A Subunit/
Activin A; Inhbb, Inhibin Beta B Subunit/Activin B; Lipe, Lipase E, Hormone Sensitive Type; Lpin1, Lipin 1; Lpin2, Lipin 2;
Lpin3, Lipin 3; Lpl, Lipoprotein Lipase; Lum, Lumican; Mdh2, Malate Dehydrogenase 2; Mfn1, Mitofusin 1; Mfn2, Mitofusin 2;
Mgll, Monoglyceride Lipase; Mmp2, Matrix Metallopeptidase 2; Mmp14, Matrix Metallopeptidase 14; Msn, Moesin; Mstn,
(continued on next page)
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Many ECM genes, such as type I, III, IV, VI, and XIV
collagen, elastin, lumican, thrombospondin 4, and tenas-
cin C were up-regulated at the 10- or 30-d time points, as
were the fibroblastmarkers S100A4 and scleraxis (Fig. 7E).
Genes involved in glycolysis, such as phospho-
fructokinase, aldolase A, glyceraldehyde-3-phosphate
dehydrogenase, phosphoglycerate, and enolase 3, were
down-regulated at 10 d, with some recovery through to
60 d after injury (Fig. 7F).
For fatty acid uptake andTG synthesis genes, therewas
a general trend for down-regulation after rotator cuff tear.
Lipoprotein lipase, which hydrolyzes extracellular TGs
into fatty acids, and the fatty acid transporter CD36 were
down-regulated after injury (Fig. 7G). Acyl-CoA synthe-
tase long-chain 1 and 6, which are the major enzymes that
conjugate fatty acids into fatty acyl–CoAs in skeletal
muscle, were down-regulated at all time points after
injury, as were AGPAT9/glycerol-3-phosphate acyl-
transferase 3 andglycerol-3-phosphate acyltransferase 1,
mitochondrial, which convert fatty acyl–CoAs into lyso-
phosphatidic acids (Fig. 7G). Additional genes that were
down-regulated include the AGPAT1, AGPAT3, and
AGPAT6 enzymes that produce phosphatidic acid from
lysophosphatidic acid, lipins 1–3,whichdephosphorylate
phosphatidic acid to produce DG and diacylglycerol O-
acyltransferase (DGAT) 1andDGAT2,whichproduceTG
from DGs (Fig. 7G). Whereas TG synthesis genes were
down-regulated, the lipid droplet coating gene perilipin 2
was up-regulated 10 d after rotator cuff tear, and Plin5
was down-regulated. Genes involved with hydrolyzing
lipids stored in droplets in fatty acids, including PLNA2,
PNPLA3, and PNPLA7, hormone-sensitive lipase, and
monoglyceride lipase, were all down-regulated after in-
jury (Fig. 7G and Table 2).
Enzymes that are responsible for the transport of fatty
acids into themitochondria, and their conversion into fatty
acyl–CoAs, acyl-CoA synthetase medium chain family
member 5, Acyl-CoA synthetase short chain family
member 1, CPT1B, carnitine acylcarnitine translocase, and
CPT2, were down-regulated at 10 and 30 d after injury,
although some recovery occurred by 60 d (Fig. 7H). For
genes involved in b-oxidation of fatty acyl CoAs within
the mitochondria, the short-, medium-, and long-chain
acyl-CoA dehydrogenases (ACADs) (Acads, Acadm, and
Acadl) were all down-regulated at 10 and 30 d after injury
(Fig. 7H).
Similar to b-oxidation genes, Krebs cycle and oxidative
phosphorylation transcripts were also down-regulated
after muscle injury, including citrate synthase, aconitase,
isocitrate dehydrogenase, 2-oxoglutarate dehydrogenase,
succinyl CoA synthetase, succinate dehydrogenase, fu-
marase,malate dehydrogenase,NDUFS1, cytochromeC1,
Myostatin; Mustn1, Musculoskeletal, Embryonic Nuclear Protein 1; Mybpc1, Myosin Binding Protein C, Slow Type; Mybpc2,
Myosin Binding Protein C, Fast Type; Myh1, Myosin, Heavy Chain 1, Skeletal Muscle, Adult (IIX); Myh2, Myosin, Heavy Chain 2,
Skeletal Muscle, Adult (IIA); Myh3, Myosin, Heavy Chain 3, Skeletal Muscle, Embryonic; Myh4, Myosin Heavy Chain 4 (IIB);
Myh7, Myosin Heavy Chain 7 (I); Myh8, Myosin, Heavy Chain 8, Skeletal Muscle, Perinatal; Myl1, Myosin Light Chain 1; Mypn,
Myopalladin; Ndufs1, Nadh:Ubiquinone Oxidoreductase Core Subunit S1; Nedd4, Neural Precursor Cell Expressed,
Developmentally Down-Regulated 4, E3 Ubiquitin Protein Ligase; Nfe2l2, Nuclear Factor, Erythroid 2 Like 2; Nrf1, Nuclear
Respiratory Factor 1; Ogdh, Oxoglutarate Dehydrogenase; Pdgfb, Platelet Derived Growth Factor Subunit B; Pfkm,
Phosphofructokinase, Muscle; Pgam2, Phosphoglycerate Mutase 2; Pgk1, Phosphoglycerate Kinase 1; Pkm, Pyruvate Kinase,
Muscle; Plin2, Perilipin 2; Plin5, Perilipin 5; Pnpla3, Patatin Like Phospholipase Domain Containing 3; Pnpla7, Patatin Like
Phospholipase Domain Containing 7; Ppargc1a, Pparg Coactivator 1 Alpha; Prdx1, Peroxiredoxin 1; Psma6, Proteasome Subunit
Alpha 6; Psmb2, Proteasome Subunit Beta 2; Pygm, Phosphorylase, Glycogen, Muscle; S100a4, S100 Calcium Binding Protein
A4/fibroblast specific protein-1; Scx, Scleraxis; Sdha, Succinate Dehydrogenase Complex Flavoprotein Subunit A; Slc25a20,
Solute Carrier Family 25 Member 20; Sod1, Superoxide Dismutase 1, Soluble; Suclg1, Succinate-Coa Ligase Alpha Subunit; Tfam,
Transcription Factor A, Mitochondrial; Tgfb1, Transforming Growth Factor Beta 1; Thbs4, Thrombospondin 4; Timp1, Timp
Metallopeptidase Inhibitor 1; Timp2, Timp Metallopeptidase Inhibitor 2; Tnc, Tenascin C; Tnmd, Tenomodulin; Tnni2,
Troponin I2, Fast Skeletal Type; Trim63, Tripartite Motif Containing 63/Muscle-Specific RING Finger Protein 1 (MuRF-1); Txn1,
Thioredoxin; Vcl, Vinculin.
TABLE 1. Gene enrichment analysis
P value
Pathway or Function 0 d vs. 10 d 0 d vs. 30 d 0 d vs. 60 d
Oxidation of fatty acid 1.14E205 1.43E204 3.13E204
Concentration of lipid 1.00E204 1.26E204 6.14E205
Accumulation of fatty acid 3.78E205 3.33E204 6.03E204
Synthesis of lipid 3.62E204 4.57E206 1.16E209
Disorder of lipid metabolism 8.00E209 5.42E204 —
Mitochondrial dysfunction 1.06E223 — —
Metabolism of carbohydrate — 6.65E205 2.79E206
Production of ROS 7.21E211 7.06E207 2.55E207
Muscle contraction 5.99E214 1.53E205 2.41E205
Growth of connective tissue 3.18E204 1.04E204 1.78E207
Inflammatory response 4.89E207 5.66E208 4.97E213
P values of selected biologic pathways and functions identified from IPA.
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COX4 (Cox4i1), and ATP5G1 (Fig. 7H). Genes involved in
mitochondrial biogenesis, such as PGC1a (Ppargc1a) and
NRF1, were down-regulated 10 d after injury, with no
difference in transcription factor A, mitochondrial
(Tfam) expression observed until 30 and 60 d (Fig. 7H).
Mitofusin (MFN) 1 and MFN2, which promote mitochon-
drial fission, were also down-regulated after rotator cuff
tear (Fig. 7H).
Genes involved in ROSmetabolismwere generally up-
regulated 10 d after injury, including catalase, glutathione
peroxidase 3, and thioredoxin, whereas others, such as
glutathione peroxidase 1, PRDX1, and superoxide dis-
mutase, were elevated at 60 d compared with controls
(Fig. 7I). Although mitochondrial b-oxidation genes were
down-regulated, oxidation of fatty acids can also occur in
peroxisomes in a processmediated by acyl-CoA oxidase 1
(ACOX1), which was up-regulated 10 d after injury. In
addition to initiating the oxidation of fatty acyl–CoAs,
ACOX1producesH2O2 that is buffered in peroxisomes by
catalase, which was markedly up-regulated 10 d after in-
jury (Fig. 7I).v-Oxidation of fatty acids can also occur as a
way to generate acetyl-CoA during times of stress in a
process regulated by cytochrome P450 family 4 subfamily
Bmember 1, whichwas up-regulated after injury (Fig. 7I).
Following the analysis of transcriptional changes, we
next sought to determine changes in the proteome after
muscle injury. A selection of the 632 proteins detected are
presented in Fig. 8. The PC analysis demonstrated that the
control and 10-d groupswere unique from each other and
the 30- and 60-d groups, whereas the 30- and 60-d groups
showed some overlap (Fig. 8A). In most cases, we saw
general agreement between observed changes in mRNAs
and the proteins they encode, including those involved
with protein synthesis and atrophy (Fig. 8B), contractile
and structural proteins (Fig. 8C), ECM proteins (Fig. 8D),
metabolic proteins (Fig. 8E), and ROS proteins (Fig. 8F).
Finally, asmetabolomic, transcriptomic, and proteomic
analyses suggested alterations in lipid oxidation, we
sought to evaluate the abundance of lipid species and
proteins that are important in mitochondrial function and
the ability of mitochondria to oxidize substrates after ro-
tator cuff tear. Whereas virtually no mitochondria were
observed in the peripheral space of control muscles, ex-
tensive accumulation of peripheral mitochondria was
notedaftermuscle injury (Fig. 9A). Therewasno change in
the ratio of mtDNA:gDNA (Fig. 9B). Acylcarnitines and
L-carnitine, which shuttle fatty acids between the cytosol
and mitochondria, were reduced at all time points after
injury (Fig. 9C–F). Cardiolipins, which are phospholipids
found almost exclusively within the inner mitochondrial
membrane, were reduced 10 d after injury but recovered
thereafter (Fig. 9G). Glutathionylated proteins (Fig. 9H)
and 2 proteins that are critical in mitophagy, PINK1 (Fig.
9I) and parkin (Fig. 9J), were elevated after injury along
with ULK1 (Fig. 9K) and p62 (Fig. 9L), which play critical
roles in mitophagy and autophagy in general. The hy-
drogen peroxide scavenging enzymes Prdx3 and Prdx6
were elevated 10 d after injury, and Prdx3 remained ele-
vated at 30 and 60 d (Fig. 9M, N). SDHA and COX4 are 2
critical proteins in mitochondrial respiration, and al-
thoughsuccinatedehydrogenasewas reducedafter injury,
COX4 abundance was not different between control and
injuredmuscles (Fig. 9O,P).After assessing theabundance
of proteins important in mitochondrial physiology, we
then performed assays to determine the functional ca-
pacity of mitochondrial proteins to metabolize substrates.
Complex I, II, and IV activitywas reduced 10d after injury
but recovered by 30 d (Fig. 9Q–S). Similar results were
TABLE 2. Changes in gene expression measured by qPCR
Gene 0 d 10 d 30 d 60 d
Capn2 (m-calpain) 1.00 6 0.09 14.3 6 5.23a 11.8 6 4.33a 12.9 6 4.81a
Cd36 (fatty acid translocase) 1.00 6 0.14 0.21 6 0.05a 0.38 6 0.12a 0.54 6 0.21a,b
Col1a1 (Collagen, type I,
alpha 1)
1.00 6 0.32 9.32 6 2.73a 8.61 6 3.80a 4.80 6 0.72a,b,c
Cpt1b (carnitine
palmitoyltransferase 1B)
1.00 6 0.14 0.32 6 0.11a 0.45 6 0.12a 0.63 6 0.21a,b
Dgat1 (diacylglycerol
O-acyltransferase 1)
1.00 6 0.26 0.43 6 0.10a 0.47 6 0.13a 0.68 6 0.19a
Fbxo30 (F-box protein 30) 1.00 6 0.32 8.15 6 1.99a 7.95 6 3.22a 4.38 6 1.24a,b,c
Il1b (Interleukin 1 beta) 1.00 6 0.38 9.32 6 4.22a 6.83 6 2.28a 4.22 6 1.87b
Myh1 (myosin heavy chain IIX) 1.00 6 0.37 0.23 6 0.11a 2.85 6 0.68a,b 1.32 6 0.56b,c
Myh2 (myosin heavy chain IIA) 1.00 6 0.09 0.15 6 0.08a 1.29 6 0.45b 1.52 6 0.38a,b
Myh3 (myosin heavy chain
embryonic)
1.00 6 0.41 19.8 6 8.11a 39.5 6 12.6a,b 17.4 6 8.89a,c
Myh4 (myosin heavy chain IIB) 1.00 6 0.29 0.68 6 0.12 0.64 6 0.28a 0.32 6 0.09a,b
Myh7 (myosin heavy chain I) 1.00 6 0.12 0.19 6 0.09a 0.54 6 0.10a,b 0.93 6 0.37b,c
Plin2 (perilipin 2) 1.00 6 0.11 23.4 6 7.31a 28.9 6 4.92a 7.92 6 1.08a,b,c
Pnpla2 (ATGL, adipose
triglyceride lipase)
1.00 6 0.21 0.48 6 0.12a 0.64 6 0.15a 0.81 6 0.21b
Prdx1 (peroxiredoxin 1) 1.00 6 0.15 2.98 6 0.34a 2.55 6 0.63a 1.41 6 0.42b,c
Gene expression is normalized to the stable housekeeping gene eukaryotic translation initiation
factor 2B subunit beta and further normalized to the 0-d group. Values are expressed as means 6
coefficient of variation, n = 4 per group. Post hoc sorting (P , 0.05). aDifferent from 0 d. bDifferent from
10 d. cDifferent from 30 d.
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observed when we evaluated the ability to oxidize pyru-
vate and palmitate, with an insufficiency 10 d after injury
but recovery thereafter, with pyruvate oxidation nearly
doubling 60d after rotator cuff tear comparedwith control
muscles (Fig. 9T, U).
DISCUSSION
Myosteatosis is a common pathologic change observed in
certain skeletal muscle groups following injury and is
particularly pronounced in the rotator cuff (7, 8). Fat ac-
cumulation is associated with greater muscle weakness
and dysfunction in patients with rotator cuff tears (8, 11),
and the mechanisms that lead to lipid accretion in myo-
steatosis are not well understood. Using a translational rat
model of myosteatosis, we evaluated changes in muscle
fiber force production, broadly profiled the changes in the
muscle lipidome, metabolome, transcriptome, and pro-
teome, and utilized bioinformatics techniques to help
identify potential factors that lead to fat accumulation in
myosteatosis. Testing of muscle fiber force, along with
electron micrographs, demonstrated a reduction in force
production that accompanied disruptions to myofibril
alignment and cytoskeletal architecture. Based on the
transcriptional bioinformatics and supporting lipidomics,
metabolomics, and electron micrographs, we then formu-
lated the hypothesis that pathologic lipid accumulation
occurs in torn rotator cuffs because of mitochondrial dys-
function and reduced lipid oxidation. In support of this
hypothesis, we observed a reduced capacity of mitochon-
dria to oxidize lipids early in the injury process, alongwith
transcriptional changes indicativeof increased lipiddroplet
storage with reduced fatty acid uptake and mobilization
from lipiddroplet stores.Althoughmitochondrial function
appears to recover at later time points, there is a general
increase in glycolytic metabolites in muscles and a greater
capacity to oxidize pyruvate. These findings support the
notion that myosteatosis occurs because of a reduction in
mitochondrial lipid oxidation and not increased uptake of
Figure 8. Changes in the proteome after
rotator cuff tear. A) Principal component
(PC) analysis of overall changes across the
proteome. B–F) Levels of selected protein
synthesis and atrophy proteins (B), contractile
and structural proteins (C), ECM proteins (D),
metabolic proteins (E), and ROS proteins (F)
as measured by mass spectrometry. n = 4
muscles per group. Post hoc sorting (P ,
0.05): a, different from 0 d; b, different from
10 d; c, different from 30 d.
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Figure 9. Changes in mito-
chondria abundance and
function after rotator cuff
tear. A) Representative elec-
tron micrographs taken at the
sarcolemma, with arrowheads
demonstrating accumulation
of peripheral subsarcolemmal
mitochondria. Scale bar for
each panel is 2 mm. B–U)
Copies of mtDNA abundance
to gDNA abundance. Short-
chain (#5 carbon) acylcarni-
tines (C ), medium-chain
(6–12 carbon) acylcarnitines
(D), long-chain (13–20 car-
bon) acylcarnitines (E ),
L-carnitine (F), and cardioli-
pins (G) as measured by mass
spectrometry and presented
as relative peak intensity
(RPI). Quantification of West-
ern blot band densitometry
of glutathionlylated proteins
(H), PINK1 (I), Parkin (J ),
Ulk1 (K), p62 (L), Prdx3
(M), Prdx6 (N), SDHA (O),
and COX4 (P) protein levels,
with representative blots shown
as insets. Enzymatic activity
of complex I (Q), complex II
(R), and complex IV (S) is
shown. Oxidation rates of 14C-
pyruvate (T) and 14C-palmitate
(U) are shown. Data are pre-
sented means 6 SD, n = 6
muscles per group (B); n = 5
muscles per group (C–F); n =
10 muscles per group (G); n =
3 muscles per group (H–P);
n = 4–6 muscles per group
(Q–U). Post hoc sorting (P ,
0.05): a, different from 0 d; b,
different from 10 d; c, different
from 30 d.
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circulating lipids into the muscle. A summary of the path-
ologic changes that occur after rotator cuff tear, and the
relationshipsbetween thesechanges, ispresented inFig. 10.
Shoulder weakness is a common observation in pa-
tients with rotator cuff tears, and this often does not re-
cover even after successful repair of the torn tendon and
completion of postoperative rehabilitation and strength-
ening programs (8, 11, 33). Satellite cells, which are myo-
genic progenitor cells that play an important role in
regenerating muscle after injury, are found in equal
abundance between untorn and fully torn rotator cuffs
and display similar in vitro proliferative and fusion ca-
pacity (34), indicating that altered satellite cell activity is
unlikely to be responsible for the persistent dysfunction in
patients who undergo rotator cuff repair. Despite appar-
ently normal satellite cells, disordered sarcomere organi-
zation and reduced muscle force production has been
reported in patients with chronic rotator cuff tears and
animalmodels of chronic rotator cuff disease (1, 11, 12, 35,
36). However, less was known about subacute changes in
contractile function after rotator cuff tear and how the
changesoccurover time. In the current study,weobserved
a reduction in force production that occurred 10d after the
injury, continuing to decline by 30 d, with some recovery
by 60 d. Centrally located nuclei were observed at 10 d,
indicative of a regenerative response corresponding to
satellite cell activation and myotube fusion occurring
around this time point. Electron micrographs demon-
strated early sarcomere streaming, with the most grossly
disorganized appearance of myofibrils at 30 d. By 60 d,
myofibril organization improved, but with persistent
z-discmalalignment that likely contributed to the reduced
specific force at this time point. Numerous sarcomeric
genes and proteins displayed marked changes in
abundance at the 10 and 30 d time points, further
suggesting active myofibril remodeling occurring at
these time points that tapers to some extent by 60 d.
Genes and proteins involved with protein degrada-
tion, such as the E3-ligases MUSA-1, atrogin-1, MuRF-
1, and NEDD4 and the calcium-dependent protease
m-calpain (37) were induced at 10 d. In agreementwith
these findings, the abundance of 2 important proteins
in the 20S catalytic subunit of the 26S proteasome,
PSMA6 and PSMB2 (38), were also increased after
muscle injury. TGF-b, which can induce muscle atro-
phy by activating proteasomal protein degradation
(39), was induced after injury, although, surprisingly,
no differences in the closely related genes activin A
and B and a down-regulation in myostatin (40) was
observed. IL-1b, which can promote inflammation and
muscle atrophy through activating the NFkB pathway
(41), was elevated across all injury time points.
IGF1, which is activated by exercise and can induce
muscle hypertrophy through the Akt/p70S6K pathway
(37) was up-regulated after injury, but interestingly,
phosphorylation of the IGF1 receptor was reduced 30 and
60 d after rotator cuff tear. Although the reason for this is
not known, DG- and ceramide-induced inflammation,
lipotoxicity, and mitochondrial dysfunction are known to
activate various serine and threonine kinases that block
activation of the insulin receptor in patients with type 2
diabetes (42). Although the lipotoxic and inflammatory
environment is greater in these injuredmuscles thanwhat
is observed in type 2 diabetes, given the homologies be-
tween the insulin and IGF1 receptors, it is possible that
similar mechanisms are inhibiting activation of the IGF1
receptor after rotator cuff tear. Phosphorylation of ERK1/
2,which is a kinase downstreamof IGF1 and several other
mechanosensitive pathways in skeletal muscle (43), was
also reduced after rotator cuff tear. IGF1 can activate
p70S6Kpathway throughboth anAkt/mammalian target
of rapamycin–dependent phosphorylation of the T389 res-
idue (44) and ERK1/2 through the T421/S424 residues
(45). Although p70S6K is a well-known activator of rpS6
(46), numerous other signaling pathways can also phos-
phorylate rpS6 (47), many of which are associated with
cellular stress and inflammation, which is likely also oc-
curring after rotator cuff tear. Additionally, p70S6K acti-
vation is required for increasing muscle force during
growth (48), suggesting a potential role for p70S6K in the
translation of myofibrillar mRNAs. For rotator cuff tears,
because many patients continue to develop muscle atro-
phyandhavepersistentweakness after surgical repair and
rehabilitation (8), it is possible that the reason the muscles
of these patients fails to recover is suppression of the IGF1
signaling pathway that is normally activated in response
to exercise.
In addition to muscle atrophy, fibrosis is a common
feature of rotator cuff tears (49–51). In the current study,
10 d after injury, there was an increase in the levels of
the fibroblast marker S100A4 and several proteogly-
cans including lumican, osteoglycin, periostin, prolargin,
thrombospondin 4, and vinculin. However, fibrillar col-
lagens, measured by hydroxyproline levels, did not in-
crease until 30 and 60 d after tear, corresponding to
increases in the expression of several collagen transcripts
andotherECMcomponents at the same timepoints. These
findings indicate that pathologic changes to muscle fibers
occur prior to substantial fibrotic changes in the ECM. As
the accumulation of fibrotic ECM impairs lateral force
transmission between muscle fibers, which increases in-
jury susceptibility during lengthening contractions (52),
the changes thatoccur to theECMlikely further exacerbate
weakness following rotator cuff tear.
Although myosteatosis has been well documented in
various types of muscle injuries and diseases, little is
known about the ontogeny of fat accumulation in this
condition (5, 6). In the current study, we identified a
Figure 10. Overview of pathologic changes after rotator cuff
tear. An overview of the pathologic changes observed and
proposed that contribute to myosteatosis, weakness, and
fibrosis after rotator cuff tear.
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progressive increase in TG after injury, with TG levels at
60 d that were 3-fold higher than controls. This was con-
sistent with observations of increased lipid accumulation
observed in histology and electron microscopy. FFAs
were also elevated at 30 and 60 d after rotator cuff tear.
There was a down-regulation in nearly all of the genes
responsible for the transport of FFAs into the muscle
cells, and the synthesis of TGs from FFAs (53), including
CD36, ACSL1, ACSL6, AGPAT9/glycerol-3-phosphate
acyltransferase 3, glycerol-3-phosphate acyltransferase 1,
mitochondrial, AGPAT1, AGPAT3, AGPAT6, lipin 1-3,
and DGAT1-2. PLIN2, which coats lipid droplets and ap-
pears tobe important for lipiddroplet growthand stability
(54), was also up-regulated after rotator cuff tear, whereas
PLIN5, which also coats lipid droplets but also helps to
target fatty acids to mitochondria for oxidation (54), was
down-regulated. Consistent with these findings, genes
involved with hydrolyzing TG stored in lipid droplets
in fatty acids (53, 55) were down-regulated after injury,
including ATGL and PNPLA3, hormone-sensitive lipase,
andmonoglyceride lipase. These findings suggest that the
intrafiber fat that accumulates in myosteatosis does not
occur because of increased fatty acid transport into fibers
or de novo synthesis of fatty acids fromother substrates but
likely because of a reduction in lipolysis.
In further support of this notion, mitochondrial lipid
oxidation was also reduced 10 d after rotator cuff tear,
with a corresponding reduction in the activity of com-
plex I, II, and IV. It can be difficult to precisely measure
mitochondrial abundance, especially because mito-
chondria often exist in large, interconnected networks
throughout the muscle fiber (56), but mtDNA abun-
dance and cardiolipin levels are often used to estimate
mitochondrial mass (30, 57, 58). Although we did not
observe a difference in relative levels of mtDNA, a
transient decrease in cardiolipins was observed
10 d after rotator cuff tear. Genes involved in the
transport of fatty acids into the mitochondria and their
conversion into fatty acyl–CoAs (acyl-CoA synthetase
medium chain family member 5, Acyl-CoA synthetase
short chain family member 1, CPT1b, carnitine acyl-
carnitine translocase, and CPT2), the b-oxidation of
fatty acyl–CoAs within the mitochondria (ACADS,
ACADM, ACADL), and Krebs cycle and oxidative
phosphorylation (citrate synthase, aconitase, isocitrate
dehydrogenase, 2-oxoglutarate dehydrogenase, succinyl
CoA synthetase, SDHA, fumarase, malate dehydroge-
nase, NDUFS1, cytochrome C1, COX4, and ATP5G1)
(53, 59, 60) were all down-regulated after rotator cuff
tear, with most remaining so through 60 d after
injury. Whereas in vitro assays demonstrated a reduction
in fatty acid oxidation 10 d after injury, medium- and
long-chain acylcarnitines, which serve as markers for
the amount of fatty acids transported into mitochon-
dria (60, 61), were reduced at all postinjury time points,
suggesting a sustained reduction in fatty acid oxidation
by mitochondria in vivo. Amino acids can be metabo-
lized and eventually oxidized through the formation
of short-chain acylcarnitines (61), but these were also
reduced after muscle injury, indicating that amino
acid oxidation is not likely taking the place of lipid
oxidation as a source of energy following muscle
injury. Although mitochondrial lipid and protein oxi-
dation appear to be reduced, ACOX1, which initiates the
oxidation of fatty acids in peroxisomes (62), was also up-
regulated 10 d after rotator cuff tear. Peroxisomal oxi-
dation of lipids also generates ROS (62), which likely
contribute to the inflammatory environment in muscles
after injury.
While mitochondrial lipid oxidation appears re-
duced after rotator cuff tears, but metabolites involved
in glycolysis are enriched 30 and 60 d after injury. Genes
involved in glycolytic metabolism, such as phospho-
fructokinase, aldolase A, glyceraldehyde-3-phosphate
dehydrogenase, phosphoglycerate, and enolase 3 (63),
were down at 10 d but recovered to some extent by
60 d after injury, although glycolytic metabolites
remained elevated. The net increase in glycolytic me-
tabolites corresponded with a greater ability of mito-
chondria to oxidize pyruvate in vitro, and these findings
in combination with the reduced abundance of acyl-
carnitines suggest muscle fibers are using much less
lipid for oxidation. Furthermore, although there was an
accumulation in glycolytic metabolites, no apparent
change in myosin isoform expression is present as
would be expected when a major fiber-type transition
occurred. The overall lipid accumulation and shift to
a glycolytic phenotype that we observed in this study
is similar to findings in a mouse model of skeletal
muscle–specific CPT1b deletion in which mitochondria
had a drastically reduced ability to take up long-chain
fatty acids, resulting in an accumulation of cyto-
solic lipid droplets, as well as elevated levels of
TG and ceramides and an increase in glycolytic
metabolism (64).
Several reports involving animal and human mod-
els of skeletal muscle unloading and denervation have
identified profound mitochondrial dysfunction and
accompanying increases in ROS production that occur
after the injury (65–68). We also observed increased
markers of ROS in injured muscles, including elevated
levels of glutathionylated proteins, as well as an in-
crease in the abundance of Prdx3 and Prdx6, which
scavenge hydrogen peroxide in the mitochondria and
cytoplasm, respectively (69, 70). The production of
ROS by dysfunctional mitochondria, as suggested by
the elevation in Prdx3, likely further exacerbates the
inflammatory environment within injured rotator cuff
muscle fibers because elevated ROS has been linked to
inhibition of protein synthesis signaling pathways, the
induction of proteolytic and autophagic pathways,
and fibrosis (71, 72). To address the dysfunctional
mitochondria, injured rotator cuff muscle fibers do
appear to be activating mitophagy, as evidenced by
increased levels of PINK1 and Parkin, which target
depolarized mitochondria for breakdown in auto-
phagosomes in a processemediated byULK1 (73). p62,
which plays an important regulatory role in both
mitophagy and general autophagy (40), was also
markedly elevated at all time points after rotator
cuff tear. However, although there appears to be
an increase in mitophagy, key genes involved in
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mitochondrial biogenesis, including PGC1a, nuclear
respiratory factor 1, and transcription factor A, mito-
chondrial (74), were down-regulated after injury, as
were the mitochondrial fusion genes Mfn1 and Mfn2.
We also noted an accumulation of peripheral segment
mitochondria in torn rotator cuffs.
In the classic 2–mitochondrial population model, a
collection of peripheral mitochondria has decreased oxi-
dative capacity comparedwith thephysicallydistinctpool
of mitochondria in the myofibrillar space (75–77). In the
newly emerging view of mitochondria, in which mito-
chondria are thought to exist in a dynamic reticulum
extending from the sarcolemma to the myofibrils and ac-
tively undergo fusion and fission in continuous networks
throughout the cell, peripheral segment mitochondria
have a greater abundance of proton motive proteins,
whereas the connected intermyofibrillar mitochondria
located in the I-band have more ATP-generating proteins
for use by sarcomeres (56, 78). In the current study, the
abnormal spherical mitochondria in the peripheral space
of injured muscles at 30 and 60 d after rotator cuff tear
could reflect a mitochondrial network that has been
mechanically and biochemically disrupted; this is sup-
ported by observations in yeast in which the small mito-
chondria that bud off of larger networks of mitochondria
have a spherical appearance (79). Although the nature of
mitochondrial dysfunction in torn rotator cuffs remains
unknown, because the continuum of mitochondrial net-
works thatnormally exists inhealthy skeletalmuscle likely
requires extensive support from the cytoskeleton of the fi-
ber to maintain shape, we posit that the highly disrupted
myofibril architecture that occurs as a result of rotator cuff
tear likely interferes with the ability to form a stable inter-
myofibrillar network, resulting in mitochondrial dysfunc-
tion and subsequent lipid accumulation.
There are several limitations to this study.Although the
rat model is commonly used in the study of rotator cuff
pathology, the quadripedal nature of rats results in in-
creased relative loads transmitted through the gleno-
humeral joint and therefore greater forces transmitted
through the rotator cuff during normal locomotion in rats
than in humans. The interfiber fat accumulation pheno-
type in rats is less pronounced than what is observed in
patientswith chronic rotator cuff tears.Wealso focusedon
pathologic fatty changes within muscle fibers, although
the adjacent adipocytes are likely important in contribut-
ing to pathologic changes as well. The tendons of rats will
spontaneously reattach to the humerus or surrounding
soft tissue through a fibrous scar, which does not occur in
humans; therefore, a tenectomy must be performed to
chronically unload the SSP muscle of rats. Additionally,
humans and large animals of rotator cuff injury develop a
combination of inter- and intrafiber lipid accumulation,
with the intrafiber accumulation occurring through an
expansion of adipocytes. We only evaluated rats with a
rotator cuff tear and did not evaluate changes that occur
within the muscle after the tear is repaired. Although we
measured transcriptional changes in myosin isoforms, we
did not directly perform histologic fiber type analysis. We
also did not demonstrate a direct causal mechanism be-
tween mitochondrial dysfunction and pathologic lipid
accumulation, although experiments inwhichmitochondria
are directlymanipulated and lipid transport and storage are
measured would add further understanding to the mecha-
nism of rotator cuff dysfunction proposed in this paper. A
total of 3 postinjury time points were selected to look at
subacute, early chronic, and chronic changes in the muscle,
but extending the evaluation to early and later time points
would likely add additional information about the pathol-
ogy. Finally, only male rats were studied, but we think the
resultsare informativeof rotatorcuffpathology inbothsexes.
Rotator cuff tears are among the most prevalent upper
extremity disorders and can result in profound pain and
disability that persist despite surgical repair (8, 9, 80).
Although surgical techniques have evolved to improve
the repair of the torn tendon back to its insertion on the
humerus, our ability to treat the extensivemuscle atrophy
and myosteatosis that occur subsequent to the tear is
limited (1, 7). The findings from this study demonstrate
that the accumulation of fat in torn rotator cuffs likely
occurs because of deficits inmitochondrial lipid oxidation
and likely leads to a lipid-induced proinflammatory and
lipotoxic state, which reduces regeneration. Further ex-
ploration of therapies to enhance mitochondrial function
and increase lipid oxidation may lead to improvements
for patientswith rotator cuff tears andothermyosteatosis-
related conditions.
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